Sophie Grigolo | Immunology and Microbiology | Young Researcher Award

Mrs. Sophie Grigolo | Immunology and Microbiology | Young Researcher Award

University of Fribourg | Switzerland

Mrs. Sophie Grigolo is an emerging researcher specializing in cellular and molecular biology, with a strong focus on cancer research, particularly clear-cell renal-cell carcinoma (ccRCC). Her work encompasses extensive laboratory expertise in cell culture using human kidney cancer cell lines (A-498, ACHN, Caki-1, and Caki-2) and a range of analytical assays including BrdU Cell Proliferation, MTT, LDH, and Live-or-Dye™ Fixable Viability Staining. She is proficient in advanced molecular biology techniques such as polymerase chain reaction (PCR), agarose gel electrophoresis, western blotting, genotyping, flow cytometry, and immunohistochemistry (IHC), which she applies to elucidate cancer cell behavior and therapeutic responses. Her publications, including studies on immunotherapy in ccRCC and the role of IL-2 receptor expression in renal carcinoma cells, contribute to advancing understanding of tumor immunology and targeted therapies. Sophie has also shared her findings at prestigious scientific forums, including the International Student Congress of (bio)Medical Sciences and the Annual European Student Symposium on Anatomical Research, where her work has earned recognition for excellence. Through her research and technical acumen, she continues to contribute to the evolving field of cancer biology and the development of innovative therapeutic approaches.

Profile : Orcid

Featured Publications

Grigolo, S., Fellay, I., & Filgueira, L. (2025). IL-2 receptor expression in renal cell carcinoma cells: IL-2 influences cell survival and induces cell death. Current Issues in Molecular Biology, 47(10), 830.

Grigolo, S., & Filgueira, L. (2024). Immunotherapy of clear-cell renal-cell carcinoma. Cancers, 16, 2092.

Anita Kavrakova | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Mrs. Anita Kavrakova | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Genetic Medico-Diagnostic Laboratory “Genica” | Bulgaria

Mrs. Anita Kavrakova is a distinguished molecular biologist and project manager with extensive experience in medical genetics and diagnostic research. Since 2019, she has been serving as Project Manager at Genetic Medico-Diagnostic Laboratory “Genica” and Genome Center Bulgaria AD in Sofia, where she oversees laboratory projects, implements innovative diagnostic techniques, ensures compliance with national and international standards, and actively contributes to scientific research through conferences, publications, and collaborative studies. Prior to this role, she worked as a Molecular Biologist at Genica (2008–2018), conducting advanced molecular analyses including PCR, qPCR, gene sequencing, and immunohistochemistry, with a focus on cancer genetics, particularly prostate and cervical cancers. She has also been a part-time assistant at the Department of Medical Chemistry and Biochemistry, Medical University Sofia, since 2012, training students in theoretical and practical biochemistry. Dr. Kavrakova earned her PhD in Genetics from Medical University Sofia in 2015, investigating molecular markers in prostate cancer for improved diagnostics and patient management, following an MS in Genetics and a Bachelor in Biology from Sofia University “St Kliment Ohridski.” She has contributed to numerous national and international research projects on infectious agents, reproductive failure, and cancer etiology, authored multiple publications, and actively participates in innovation evaluation and scientific advisory roles, demonstrating leadership, analytical skills, and a commitment to advancing molecular diagnostics and biomedical research.

Profiles : Scopus | Orcid

Featured Publications

Todorova, E., Kavrakova, A., Derimachkovski, G., Georgieva, B., Odzhakov, F., Bachurska, S., Terziev, I., Boyadzhieva, M. E., Valkov, T., Popov, E., Slavov, C., Tourtourikov, I., Mitev, V., & Todorova, A. (2025). Human Herpes Virus genotype and immunological gene expression profile in prostate cancer with prominent inflammation. International Journal of Molecular Sciences, 26(10), 4945.

Todorova, E., & Kavrakova, A., Derimachkovski, G., Georgieva, B., Kalenderova, S., Odzhakov, F., Bachurska, S., Boyadzhieva, M. E., Terziev, I., Genova, M., Mitev, V., & Todorova, A. (2025). Pathogenic contribution of human papillomaviruses and Epstein-Barr virus to prostate cancer in Bulgarian patients. C. R. Acad. Bulg. Sci. (submitted).

Mesechkova, K., Kavrakova, A., Georgieva, B., Sigridov, I., Miteva, A., Mitev, V., & Todorova, A. (2023). Bacterial and viral pathogens implicated in female reproductive failure investigated on menstrual blood. C. R. Acad. Bulg. Sci., 76(3), 394–406.

Mesechkova, K., Kavrakova, A., Georgieva, B., Sigridov, I., Mitev, V., & Todorova, A. (2023). Non-invasive diagnostics of reproductive failure with infectious etiology on menstrual tissue. Acta Medica Bulgarica, 50(3).

Mesechkova, K., Kavrakova, A., Todorova, E., Georgieva, B., Sigridov, I., Mitev, V., & Todorova, A. (2023). Role of bacterial and viral infections and co-infections in miscarriages. Acta Medica Bulgarica, 50(4).

Kavrakova, A., Todorova, A., Georgieva, B., Anachkov, K., Yanev, K., Ivanov, G., & Mitev, V. (2018). Investigation of noninvasive urine specimens with molecular fluctuations for a presence of high-risk human papilloma viruses as an inflammatory cofactor in prostate cancer. Journal of Biology and Medicine.

Tsvetkova, A., Todorova, A., Todorov, T., Georgiev, G., Drandarska, I., & Mitev, V. (2015). Molecular and clinico-histological data in aggressive prostate cancer patients from Bulgaria. JBUON, 20(2).

Tsvetkova, A., Todorova, A., Todorov, T., Georgiev, G., Drandarska, I., & Mitev, V. (2015). Molecular and clinicopathological aspects of prostate cancer in Bulgarian probands. Journal of Pathology and Oncology Research.

Tsvetkova, A., Todorova, A., Todorov, T., Georgiev, G., Drandarska, I., & Mitev, V. (2014). Molecular profile and clinicopathological aspects of prostate cancer in Bulgarian patients. Journal of BOD, 4, 18–26.

Tsvetkova, A., Kadiyska, T., Georgiev, G., Drandarska, I., Todorova, A., & Mitev, V. (2013). Molecular-genetic approach in combination with clinical and histological data for diagnostics of prostate cancer. Journal of Oncology, 3, 50–55.

 

 

Giovanni Nigro | Immunology and Microbiology | Best Researcher Award

Prof. Giovanni Nigro | Immunology and Microbiology | Best Researcher Award

Nonprofit Association of Mother–Infant Cytomegalovirus Infection | Italy

Author Profile

Scopus

Orcid

👨‍🎓 Early Academic Pursuits

Prof. Giovanni Nigro began his medical journey with an enduring passion for pediatrics and infectious diseases. Specializing in Pediatrics, Gastroenterology, and Infectious Diseases, he built a multidisciplinary foundation that enabled him to bridge clinical care with research excellence. His academic expertise quickly led him to become a leading figure in pediatric medicine at the University of L’Aquila, Italy, where he served as Director of the Pediatric Unit and School of Pediatrics.

🌍 Professional Endeavors

Prof. Nigro has an international footprint in medical education and research. His visiting professorships at elite institutions—such as St. George’s Hospital Medical School (London), the Swedish Institute for Infectious Disease Control (Stockholm), the Central Public Health Laboratory (London), and the Medical College of Virginia—reflect his global influence and leadership in pediatric infectious diseases. Through lectures and collaborative research, he has mentored countless young professionals and enriched the global pediatric and virology communities.

🔬 Contributions and Research Focus

A prolific scholar, Prof. Nigro has authored or co-authored over 330 publications, with 74 appearing in high-impact peer-reviewed journals. His research focuses prominently on congenital cytomegalovirus (CMV) infection, maternal-fetal infections, and pediatric virology. He is internationally recognized for his groundbreaking work in hyperimmune globulin therapy, antiviral treatments, and CMV disease outcomes. His recent studies, including clinical trials on CMV prevention, have reshaped treatment protocols and improved neonatal health outcomes globally.

🏅 Accolades and Recognition

Prof. Nigro is a highly respected figure in the international medical community. He has served as a referee for prestigious journals such as The Lancet, Journal of Pediatrics, Clinical Infectious Diseases, and Gastroenterology. His contributions are frequently cited in leading textbooks like Harrison’s Internal Medicine, Nelson Textbook of Pediatrics, and Remington & Klein’s Infectious Diseases of the Fetus and Newborn Infant, cementing his role as a pioneer in his domain.

💡 Impact and Influence

Prof. Nigro’s influence transcends academia. His clinical insights and translational research have significantly impacted public health policies and therapeutic guidelines for managing congenital CMV. He has been a key collaborator with renowned experts worldwide, from Sweden and the UK to the US and Germany, facilitating international research initiatives that continue to yield global health benefits.

🌟 Legacy and Future Contributions

Prof. Nigro’s legacy lies in his enduring contributions to pediatric infectious disease management and his role as a mentor and thought leader. With recent impactful publications in Viruses, NEJM, and Clinical Infectious Diseases, he continues to drive forward innovations in antiviral therapies and fetal medicine. His work remains crucial in addressing maternal-fetal health challenges, ensuring a healthier start to life for future generations.

Publications


📄 Foscarnet versus ganciclovir for severe congenital cytomegalovirus infection: Short- and long-term follow-up
Authors: Nigro G, Buzzi M, Catenaro M, Coclite E, Muselli M
Journal: Viruses
Year: 2025


📄 Prevention of congenital cytomegalovirus infection: Review and case series of valaciclovir versus hyperimmune globulin therapy
Authors: Nigro G, Muselli M
Journal: Viruses
Year: 2023


📄 Hyperimmune globulin for congenital cytomegalovirus infection
Author: Nigro G
Journal: The New England Journal of Medicine
Year: 2022


📄Serial Monitoring and Hyperimmunoglobulin versus Standard of Care to Prevent Congenital Cytomegalovirus Infection: A Phase III Randomized Trial
Authors: Devlieger R, Buxmann H, Nigro G, et al.
Journal: Fetal Diagnosis and Therapy
Year: 2021


📄 High-dose cytomegalovirus (CMV) hyperimmune globulin and maternal CMV DNAemia independently predict infant outcome in pregnant women with a primary CMV infection
Authors: Nigro G, Adler SP; Congenital Cytomegalic Disease Collaborating Group
Journal: Clinical Infectious Diseases
Year: 2020


Ioannis Tsakmakidis | Veterinary Science and Veterinary Medicine | Best Researcher Award

Dr. Ioannis Tsakmakidis | Veterinary Science and Veterinary Medicine | Best Researcher Award

University of Macedonia | Greece

Author profile

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Ioannis Tsakmakidis commenced his academic journey at the Aristotle University of Thessaloniki, where he obtained his Veterinary Medicine degree in 1993 with a commendable performance (Grade: Very Good). He advanced his specialization through a Master of Science (MSc) degree in 2013, concentrating on the feeding and pathology of pigs and poultry, with distinction (Grade: Excellent). His academic rigor culminated in the completion of a Doctorate (PhD) in 2019 at the Laboratory of Parasitology and Parasitic Diseases, where he investigated the ecological role of various animal species in the transmission cycles of Leishmania spp., receiving the highest academic distinction.

🩺 Professional Endeavors

Professionally, Dr. Tsakmakidis has served extensively as a veterinarian in both public and private sectors. Since 2003, he has held the position of Civil Servant Veterinarian at the Directorate of Rural Affairs in Thessaloniki, contributing significantly to EU co-funded initiatives that enhance livestock sector modernization. Prior engagements include managing his own companion animal clinic and serving as an associate veterinarian at ALMAPET, where he provided a wide range of services, including soft tissue and orthopedic surgery, parasitic disease management, and dental care.

🔬 Contributions and Research Focus

Dr. Tsakmakidis' research trajectory is rooted in veterinary parasitology, public health, and sustainable livestock systems. He is currently a postdoctoral researcher investigating Greek buffalo farming systems, with a particular focus on the zoonotic parasite Toxoplasma gondii and the quality assessment of buffalo meat and milk. His involvement in the EU-funded LIFE ATIAS project emphasizes his commitment to biodiversity and the management of invasive mammalian species. Furthermore, he participates in projects related to milk-based diagnostics for Neospora caninum and buffalo product quality, contributing to integrated agro-livestock strategies in Greece.

🏅 Accolades and Recognition

Dr. Tsakmakidis’ scholarly integrity is evidenced by his repeated appointments as a peer reviewer for high-impact international journals such as Scientific Reports, Journal of Nanobiotechnology, and Veterinary Medicine International. Additionally, he has served on the review boards of prestigious academic conferences, including the International Conference for the Promotion of Educational Innovation, where he has evaluated scientific papers across disciplines.

📘 Impact and Influence

Through a robust portfolio of peer-reviewed publications, Dr. Tsakmakidis has significantly advanced the understanding of parasitic zoonoses in non-canine hosts, including rodents, lagomorphs, minks, and buffaloes. His findings have appeared in journals such as Tropical Medicine & International Health, Veterinary Microbiology, Tropical Animal Health and Production, and AIMS Molecular Science. These contributions are critical for veterinary public health, especially in the context of antimicrobial resistance, emerging parasitic threats, and One Health paradigms. In academia, he has distinguished himself as a lecturer at both undergraduate and postgraduate levels at the University of Western Macedonia and the International Hellenic University, consistently earning evaluations above departmental averages. His teaching integrates theoretical rigor with practical insights into pig farming, anthrozoonoses, and sustainable animal production systems.

🌍 Legacy and Future Contributions

Dr. Tsakmakidis is actively shaping European veterinary science through his role in COST Action CA21111, an international consortium addressing drug development for vector-borne parasitic diseases within the One Health framework. His ongoing research on zoonotic parasite surveillance, coupled with his pedagogical engagements and commitment to sustainable agriculture, positions him as a vital contributor to both scientific progress and policy formulation in veterinary and public health domains.

Publications


📄 Flaws in Estrus Synchronization Protocols Increase Vaginal Prolapse and Hydrometra Risk in Sheep
Authors: Nikolaos Tsekouras, Ioannis Tsakmakidis, Dimitrios Gougoulis, Mathis A. B. Christodoulopoulos, Christos Kousoulis, Georgios I. Papakonstantinou, Vasileios G. Papatsiros, Georgios Christodoulopoulos
Journal: Life
Year: 2025


📄 Alternative hosts of Leishmania infantum: a neglected parasite in Europe
Authors: Ioannis Tsakmakidis, Menelaos Lefkaditis, Konstantinos Zaralis, Georgios Arsenos
Journal: Tropical Animal Health and Production
Year: 2024


📄 Prevalence of Neospora caninum and associated risk factors in semi-intensive female water buffaloes reared in Greece, using an ELISA kit on milk samples
Authors: Ioannis Tsakmakidis, Menelaos Lefkaditis, Marina Sofia, Konstantinos Zaralis, Ioannis A. Giantsis
Journal: Veterinary Parasitology: Regional Studies and Reports
Year: 2024


📄 Stray dogs as carriers of E. coli resistant strains for the retracted and reemerged antibiotic colistin, based on the mcr-1 gene presence
Authors: Ioannis Tsakmakidis, Anastasia Parisi, Dimitrios K. Papadopoulos, Maria V. Alvanou, Konstantinos V. Papageorgiou, Evanthia Petridou, Ioannis A. Giantsis
Journal: AIMS Molecular Science
Year: 2024


📄 Leishmania infection in lagomorphs and minks in Greece
Authors: Ioannis Tsakmakidis, Christoforos Pavlou, Androniki Tamvakis, Theologos Papadopoulos, Vasiliki Christodoulou, Katerina Angelopoulou, Chrysostomos I. Dovas, Maria Antoniou, Christos Anastasakis, Anastasia Diakou
Journal: Veterinary Parasitology: Regional Studies and Reports
Year: 2019


Ridwan Salaam | Biochemistry, Genetics and Molecular Biology | Editorial Board Member

Mr. Ridwan Salaam | Biochemistry, Genetics and Molecular Biology | Editorial Board Member

University of Ibadan | Nigeria

Author Profile

Orcid

Google Scholar

🌟 Early Academic Pursuits

Ridwan Salaam’s academic journey reflects a deep commitment to scientific excellence. His Bachelor’s degree from Obafemi Awolowo University (OAU) laid the foundation for his expertise in molecular genetics, with a thesis focused on the chromosomal studies of Arvicanthis niloticus. He graduated with a Second Class Upper degree, achieving a remarkable GPA of 4.19/5.0. Building on this, he pursued a Master’s degree at the University of Ibadan, earning a distinction (GPA: 6.2/7.0). His thesis investigated the antiplasmodial activity of phytocompounds using in silico pharmacology, supervised by esteemed scholars like Dr. Afolayan Funmilayo I.D.

🚀 Professional Endeavors

With hands-on research experience spanning academia and industry, Ridwan has excelled in roles such as Research Intern at Hackbio, Graduate Research Assistant at the University of Ibadan, and Research Assistant at OAU. He has mastered advanced bioinformatics tools, molecular docking, and statistical analysis, actively contributing to cancer and infectious disease studies. His contributions extend to mentoring students, conducting DNA extractions, and organizing independent research groups like the Computer-Aided Biological Research Group (COMBReG).

🧬 Contributions and Research Focus

Ridwan’s research spans Cell Biology, Molecular Genetics, Drug Discovery, and Immunotherapy, with an emphasis on cancer and infectious diseases. He has published extensively on computational drug discovery, molecular docking, and network pharmacology. Notable works include elucidating antiplasmodial mechanisms and exploring phytocompounds for cancer treatments. He has participated in groundbreaking projects, such as developing multipotent antivenom under the 2023 TETFUND National Research Fund.

🏆 Accolades and Recognition

Ridwan’s achievements have garnered national and international recognition. His certificate of commendation from Government Secondary School, Maina, acknowledges his teaching contributions, while multiple workshop certifications highlight his expertise in computer-aided drug design and vaccine development. His collaborative research efforts have been showcased at prestigious conferences like the Zoological Society of Nigeria Annual Conference and the International Conference on Scientific Research in Nigeria.

🌍 Impact and Influence

As a convener of COMBReG and a research team coordinator, Ridwan has demonstrated exceptional leadership by fostering collaborative environments and driving innovation. He has trained over 40 participants in bioinformatics and spearheaded projects addressing global health challenges like malaria and cancer. His ability to work across diverse cultural and professional backgrounds has solidified his reputation as a team player and mentor.

📜 Legacy and Future Contributions

Ridwan Salaam’s robust academic background and research endeavors position him as a trailblazer in molecular genetics and bioinformatics. His work not only addresses pressing global health issues but also inspires future generations of scientists. With ongoing research in computational drug discovery and molecular pathways, Ridwan’s contributions are poised to leave a lasting impact on the fields of cancer therapy and infectious disease treatment. His journey exemplifies the spirit of innovation and dedication, promising a legacy of transformative research.

 

Publications


📄 A Review of Selected Parasitic Plants in Nigeria: Converting Harms to Benefits

Authors: Funmilayo I. D. Afolayan, Ridwan A. Salaam, Ebenezer S. Oladokun, Samson D. Adesoye
Journal: Natural Therapy Advances
Year: 2024


📄 Antiplasmodial Mechanism of Lawsonia inermis: An In Silico-Based Investigation

Authors: Ridwan Abiodun Salaam, Funmilayo I. D. Afolayan
Journal: Infectious Diseases Research
Year: 2024


📄 In Silico Discovery of Potential Androgen Receptor and Cytochrome P450 17A1 Inhibitors from Camellia sinensis for Prostate Cancer Treatment

Authors: Ridwan Abiodun Salaam, Christopher Terseer Tarkaa, Rachael Pius Ebuh, Damilare Adebayo Olaniyi, Sayo Ebenezer Oladokun, Rodiat Omotola Sowemimo, Oluwaponmile Florence Ajayi, Olusola Abayomi Akangbe
Journal: Next Research
Year: 2024


📄 In Silico and In Vivo Evaluations of Multistage Antiplasmodial Potency and Toxicity Profiling of n-Hexadecanoic Acid Derived from Vernonia amygdalina

Authors: Funmilayo I. D. Afolayan, R. A. Odeyemi, Ridwan A. Salaam
Journal: Frontiers in Pharmacology
Year: 2024


📄 Elucidating the Molecular Targets of Curcuma longa for Breast Cancer Treatment Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation

Authors: Christopher Terseer Tarkaa, Damilare Adebayo Oyaniyi, Ridwan Abiodun Salaam, Rachael Pius Ebuh, Olusola Abayomi Akangbe, Sayo Ebenezer Oladokun, Rodiat Omotola Sowemimo, Oluwaponmile Florence Ajayi
Journal: Precision Medicine Research
Year: 2023


 

Jiang hua Yang | Medicine and Dentistry | Best Researcher Award

Dr. Jianghua Yang | Medicine and Dentistry | Best Researcher Award

Yijishan Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Jianghua Yang began his academic journey in the medical field with a focus on infectious diseases. His foundational studies laid the groundwork for a career dedicated to understanding and combating a variety of infectious diseases. Over the years, Dr. Yang has honed his expertise and developed a deep research interest in several key areas, including tuberculosis, severe fever with thrombocytopenia syndrome, schistosomiasis, and hepatitis.

Professional Endeavors

Dr. Jianghua Yang is currently associated with the Department of Infectious Diseases at Yijishan Hospital of Wannan Medical College in Wuhu, Anhui, China. In his professional role, he has undertaken significant research projects and contributed extensively to the field of infectious diseases. His work is characterized by a commitment to advancing medical knowledge and improving patient outcomes through rigorous scientific inquiry and collaboration with other researchers.

Contributions and Research Focus

Dr. Yang's research spans several critical areas in infectious diseases. His studies on tuberculosis have been published in reputable journals such as "Tuberculosis (Edinb)" and the "International Journal of Infectious Diseases". His work on severe fever with thrombocytopenia syndrome has appeared in the "Journal of Medical Virology" and the "Japanese Journal of Infectious Diseases". Additionally, Dr. Yang has investigated schistosomiasis, with his findings published in "Scientific Reports" and "Journal of Cancer". His research on hepatitis has been featured in the "European Journal of Gastroenterology & Hepatology" and "BMC Gastroenterology". These contributions have not only enhanced the understanding of these diseases but have also provided valuable insights into their diagnosis, treatment, and management.

Accolades and Recognition

Throughout his career, Dr. Yang has received recognition for his impactful research and contributions to the field of infectious diseases. His publications have been cited by peers, reflecting the significance and influence of his work. Dr. Yang's dedication to advancing medical science has earned him respect and acknowledgment within the academic and medical communities.

Impact and Influence

Dr. Yang's research has had a substantial impact on the understanding and treatment of infectious diseases. His work on tuberculosis and severe fever with thrombocytopenia syndrome has informed clinical practices and guided further research in these areas. By elucidating the complexities of diseases such as schistosomiasis and hepatitis, Dr. Yang has contributed to the development of more effective diagnostic and therapeutic strategies, thereby improving patient care and outcomes.

Legacy and Future Contributions

Dr. Jianghua Yang's legacy in the field of infectious diseases is marked by his significant research contributions and his commitment to advancing medical knowledge. As he continues his work, Dr. Yang is poised to make further groundbreaking discoveries that will enhance the understanding of infectious diseases and lead to better health outcomes worldwide. His ongoing research and dedication to scientific excellence will undoubtedly inspire future generations of researchers and healthcare professionals.

 

Notable Publications

Trends of type 2 diabetes with pulmonary tuberculosis patients,2013–2022, and changes after the coronavirus disease 2019 (COVID-19) pandemic 2024 (2)

Construction of an early differentiation diagnosis model for patients with severe fever with thrombocytopenia syndrome and hemorrhagic fever with renal syndrome 2024

Prevalence and impact of viral myocarditis in patients with severe fever with thrombocytopenia syndrome 2024

Clinicopathological characteristics and its association with digestive system tumors of 1111 patients with Schistosomiasis japonica 2023 (1)

A risk prediction model for acute kidney injury in patients with pulmonary tuberculosis during anti-tuberculosis treatment 2022 (4)

 

 

 

 

 

Deresse Daka | Immunology and Microbiology | Editorial Board Member

Assoc Prof Dr. Deresse Daka | Immunology and Microbiology | Editorial Board Member

Hawassa University | Ethiopia

Author Profile

Orcid

Early Academic Pursuits

Deresse Daka Gidebo embarked on his academic journey with a Bachelor's degree in Medical Laboratory Sciences from Jimma University in 2006. His passion for learning extended to a Diploma in Computer Sciences from Debub University Dilla College, followed by a Certificate Diploma in Bible Correspondence Study from Canada IBC College in 2005.

Professional Endeavors

With a solid foundation, Deresse pursued a Master's in Medical Microbiology at Addis Ababa University, Black Lion, graduating in 2011. Currently, he is committed to academic excellence as a Ph.D. candidate at the University of Gondar since 2021.

Contributions and Research Focus

Deresse Daka's research endeavors encompass various critical health aspects. His ongoing studies explore the prevalence, drug resistance patterns, and associated factors of M. tuberculosis among prisoners. Additionally, he investigates the antibacterial effects of Alchemilla Abyssinica extract and assesses the impact of water, sanitation, and hygiene interventions on intestinal parasites among school children in Sidama Zone.

Accolades and Recognition

Deresse has made significant contributions to education, co-authoring the Revised Community-Based Education (CBE) Implementation Guideline for Hawassa University in February 2019 and an earlier version in January 2015. Furthermore, he authored a book titled "Introduction to Immunology and Serology, Diagnostic Tool" in 2010.

Impact and Influence

Deresse's research on tuberculosis, antibacterial effects, and hygiene interventions directly addresses public health challenges. His academic contributions, including the CBE guidelines, showcase his influence on medical education methodologies.

Legacy and Future Contributions

Deresse Daka's legacy lies in bridging academia and practical healthcare. His focus on infectious diseases and community health positions him to leave a lasting impact on medical research and education. His commitment to ongoing studies and publications promises continued valuable contributions to the field.

Notable Publications

Knowledge, attitude and practice on prevention and control of pulmonary tuberculosis index cases family in Shebedino District, Sidama Region, Ethiopia 2023

Prevalence, drug-susceptibility pattern and associated factors of Mycobacterium tuberculosis infection among prisoners in western Arsi zonal prisons, Oromia, South West Ethiopia 2023 

Parental traditional medicine use for under-five children and association factors in Wolaita Sodo, Ethiopia: A cross-sectional study 2023

 

 

Izeta Aganovic Musinovic | Immunology and Microbiology | Best Researcher Award

Prof. Izeta Aganovic Musinovic | Immunology and Microbiology | Best Researcher Award

University of Sarajevo | Bosnia and Herzegovina

Author Profile

Google Scholar

Early Academic Pursuits

Izeta Aganovic Musinovic embarked on her academic journey at the Medical School, University of Sarajevo, earning her Medical Doctor degree in 1994. She further delved into Genetics, completing a Master of Science thesis on chromosomal aberrations in populations exposed to ionizing radiation during wartime.

Professional Endeavors

Her career spanned across various roles at the Centers for Human Genetics and the Department of Immunology at the University of Sarajevo, evolving from an Associate to Senior Associate. She pursued a Residency Program in Immunology, culminating in a Doctor of Science in Immunology. Her trajectory included roles as a Senior Assistant Lecturer and Assistant Professor, contributing significantly to the Department of Immunology.

Contributions and Research Focus

Aganovic Musinovic's contributions notably revolved around immunobiological markers in assessing renal function injury in multiple myeloma patients. Her research journey spanned topics encompassing genetics, hematological disorders, and immunology, evident through her thesis work and subsequent teaching roles in Immunology, Hematology, and Nephrology.

Accolades and Recognition

Her academic achievements were evident through the completion of a Doctor of Science in Immunology and a Master's thesis in Genetics, affirming her commitment to advanced research and academia. The recognition of her contributions was reflected in her appointments as Associate and subsequently as Assistant and Associated Professor at the University of Sarajevo.

Impact and Influence

Aganovic Musinovic's influence was pronounced in the field of Immunology, particularly in advancing the understanding of immunobiological markers for renal function assessment in patients with multiple myeloma. Her teaching roles and extensive research endeavors have contributed to shaping the academic landscape in genetics, immunology, and related medical disciplines.

Legacy and Future Contributions

Her legacy lies in her comprehensive exploration of immunological markers and genetic factors impacting renal function in hematological disorders. Aganovic-Musinovic's commitment to academia, coupled with her research focus, lays the groundwork for future advancements in understanding renal function, genetics, and immunology within medical contexts. Her continued dedication is poised to shape the next generation of medical professionals and drive further breakthroughs in the field.

Notable Publications

Clinical management of patients with systemic lupus erythematosus (SLE) with different C1q-CIC and C3 concentrations 2010 (10)

The Impact of Rituximab Therapy on the Chromosomes of Patients with Rheumatoid Arthritis 2010 (5)

Evaluation of ENA-6 Profile by ELISA Immunoassay in Patients with Systemic Lupus Erythematodes 2012 (4)

Sex prediction by geometric morphometric analysis of the hard palate 2022 (2)

Effects of topically applied diclofenac and ketoprofen on Prostaglandin E2 and Stat3 sera levels and body temperature in two different acute inflammation models in rats 2021 (1)